In the IL-23/Th17 axis model of psoriasis, IL-23 is able to produce and induce Th17 cell lymphocyte activation, which subsequently releases IL-17A, IL-17C, IL-17F, IL-22 and other related pro-inflammatory cytokines. Here, IL22 is linked to psoriasis.